首页 | 本学科首页   官方微博 | 高级检索  
   检索      


LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
Authors:Cao  Yongxian  Zhang  Feng  Wang  Haotian  Bi  Chunhua  Cui  Jinpeng  Liu  Fenghai  Pan  Huazheng
Institution:1.Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Qingdao, 266003, Shandong, China
;2.Department of Clinical Laboratory, Rizhao City Hospital of Traditional Chinese Medicine, Rizhao, Shandong, China
;3.Medical College, Yanbian University, Yanji, Jilin, China
;4.Department of Infectious Disease, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
;5.Department of Clinical Laboratory, Yantaishan Hospital, Yantai, Shandong, China
;6.Department of Clinical Laboratory, Qingdao Municipal Hospital, No. 5, Middle Donghai Road, Qingdao, 266071, Shandong, China
;
Abstract:Molecular and Cellular Biochemistry - Drug resistance is one of the major challenges for cancer therapies. In recent years, research on disease-related molecular signaling pathways has become the...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号